Cost-effectiveness analysis of toripalimab and bevacizumab versus sorafenib for advanced hepatocellular carcinoma in China

Z Zhiwei Zheng T Tian Liu (Key Laboratory of Photochemical Conversion and Optoelectronic Materials) Y Yuling Zhang H Huide Zhu L Ling Fang

Article Details

Volume / Issue Vol. 1, Issue 1
Published May 18, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (5)

Z

Zhiwei Zheng

T

Tian Liu

Key Laboratory of Photochemical Conversion and Optoelectronic Materials

Y

Yuling Zhang

H

Huide Zhu

L

Ling Fang